AGM/EGMJul 28, 2026, 04:56 PM
Sonoma Pharmaceuticals Schedules 2026 Annual Stockholders' Meeting
AI Summary
Sonoma Pharmaceuticals, Inc. has scheduled its 2026 Annual Stockholders' Meeting for Wednesday, September 16, 2026, at 2:00 p.m. MDT, to be held at the company's offices in Boulder, Colorado. Stockholders will vote on the election of Mr. Jerry McLaughlin as a Class III director, an advisory resolution to approve executive compensation for the fiscal year ended March 31, 2026, and the ratification of Frazier & Deeter, LLC as the independent registered public accounting firm for the fiscal year ending March 31, 2027. The Board of Directors recommends a 'FOR' vote on all proposals.
Key Highlights
- Sonoma Pharmaceuticals, Inc. will hold its 2026 Annual Stockholders' Meeting on September 16, 2026, at 2:00 p.m. MDT.
- Stockholders will vote on the election of Mr. Jerry McLaughlin as a Class III director.
- An advisory vote will be held to approve the compensation of Named Executive Officers for the fiscal year ended March 31, 2026.
- Stockholders will ratify the appointment of Frazier & Deeter, LLC as independent auditors for the fiscal year ending March 31, 2027.
- The Board recommends voting 'FOR' all proposals.
- The record date for voting is July 24, 2026, with 4,788,425 shares of common stock outstanding.
Price Impact
More from SNOA
More in AGM/EGM